DAS181
ADVERTISEMENT
- Molecular formula
- C25H25FN6
- CAS Number
- 163942-83-4
- IUPAC Name
- 4-[5-(4-fluorophenyl)-3-(4-piperidyl)imidazol-4-yl]pyrimidin-2-amine
- Molecular Weight
- 485.54g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.3400g/cm3
- Synonyms
- SB220025
Identification
Interesting facts
Interesting Facts about 4-[5-(4-fluorophenyl)-3-(4-piperidyl)imidazol-4-yl]pyrimidin-2-amine
This compound is a fascinating member of the chemical world, primarily due to its complex structure and potential applications in medicinal chemistry. Here are some striking points of interest:
- Multi-Functional Molecule: The presence of both imidazole and pyrimidine moieties indicates that this compound can interact with multiple biological targets, making it a candidate for drug development.
- Pharmacological Potential: The structural elements of this compound suggest it may have effects on the central nervous system. Compounds that include piperidine are often associated with neuropharmacological activity.
- Fluorine's Role: The incorporation of a fluorine atom can enhance the metabolic stability of the compound, potentially increasing the efficacy of the resultant drug.
- Research Applications: Due to its complex structure, this compound is likely to be of interest in studies focusing on enzyme inhibition or receptor binding, particularly in the context of cancer research or neurobiology.
- Chemical Synthesis: The synthesis of such a compound may involve various advanced techniques including but not limited to, *cross-coupling reactions*, which are staples in organic chemistry.
As a scientist or student delving into the field of chemistry, this compound serves as an excellent example of how small variations in molecular structure can lead to significant changes in biological activity. It beautifully illustrates the intricate dance between chemistry and biology, inviting investigations into its potential as a therapeutic agent.
"The beauty of chemistry lies in the details—each atom and bond tells a story."